Physician profile
Bryant Vo
NPI 1790970812
$34,203.94
in general payments reported to CMS, 2019-2025
12 companies · $663 in 2025
The $663 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.61 · 2020: $3,661 · 2021: $6,119 · 2022: $11K · 2023: $9,382 · 2024: $3,667 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $1,148 · Entertainment: $13.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,550.00 |
| Food and Beverage | $1,148.27 |
| Entertainment | $13.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $32,984.33 | 2020-2025 | Tearcare System, Omni Surgical System |
| Bausch & Lomb Americas INC. | $257.32 | 2022-2024 | Infuse |
| Lumenis Be INC | $136.77 | 2024 | Optilight |
| Kala Pharmaceuticals, INC. | $136.25 | 2021 | |
| Glaukos Corporation | $128.16 | 2021 | |
| Lumenis, INC | $122.55 | 2021 | |
| Heru, INC. | $115.16 | 2022 | |
| Coopervision INC. | $107.47 | 2023-2025 | Myday Contact Lens, Misight Contact Lens |
| Visioneering Technologies, INC. | $91.86 | 2025 | |
| Optos, INC. | $64.50 | 2019-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $42.59 | 2024-2025 | Dailies Total1, Total30 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryant Vo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.